Iovance Biotherapeutics' shares rose 36.71% to $15.03, but the story gives no business reason. It reports no new company fact, so the outlook is unchanged.
A change in share price alone does not show that Iovance's sales, treatment, or finances changed. The story gives no cause or new company information, so it does not change how we read its business.
Nautilus Biotechnology's shares rose 36.48% to $1.51, but the story gives no business reason. It reports no new company fact, so the outlook is unchanged.
Quantum-Si's shares rose 22.66% to $0.98, but the story gives no business reason. It reports no new company fact, so the outlook is unchanged.
NewGenIvf Group's shares fell 79.0% to $0.07, but the story gives no business reason. It reports no new company fact, so the outlook is unchanged.
BeyondSpring's shares fell 44.92% to $0.62, but the story gives no business reason. It reports no new company fact, so the outlook is unchanged.
uniQure's shares fell 36.77% to $24.73, but the story gives no business reason. It reports no new company fact, so the outlook is unchanged.
Follow Iovance Biotherapeutics (IOVA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for IOVA